Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-?B pathway

由 Sim M.Y., Yuen J.S.P., Go M.L.
出版 2019

Action of YM155 on clear cell renal cell carcinoma does not depend on surviving expression levels

由 Sim M.Y., Huynh H., Go M.L., Yuen J.S.P.
出版 2019

The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma

由 Yuen, J.S.P, Cockman, M.E, Sullivan, M, Protheroe, A, Turner, G.D.H, Roberts, I.S, Pugh, C.W, Werner, H, Macaulay, V.M
出版 2020

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma

由 Yuen, J.S.P, Sim, M.Y, Sim, H.G, Chong, T.W, Lau, W.K.O, Cheng, C.W.S, Ong, R.W, Huynh, H
出版 2020

Phased-array magnetic resonance imaging of the prostate with correlation to radical prostatectomy specimens: Local experience

由 Kwek J.-W., Thng C.-H., Tan P.-H., Yuen J.S.-P., Khoo J.B.-K., Quek S.-T., Ho J.T.-S., Tan K.-P., Cheng C.W.-S.
出版 2020

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

由 Thura M., Al-Aidaroos A.Q., Gupta A., Chee C.E., Lee S.C., Hui K.M., Li J., Guan Y.K., Yong W.P., So J., Chng W.J., Ng C.H., Zhou J., Wang L.Z., Yuen J.S.P., Ho H.S.S., Yi S.M., Chiong E., Choo S.P., Ngeow J., Ng M.C.H., Chua C., Yeo E.S.A., Tan I.B.H., Sng J.X.E., Tan N.Y.Z., Thiery J.P., Goh B.C., Zeng Q.
出版 2020